MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today its financial results for the Company’s first quarter ended March 31, 2009. The Company reported net income from continuing operations of $16.5 million (or $0.28 per share) for the three months ended March 31, 2009, compared to $28.6 million (or $0.49 per share) for the three months ended March 31, 2008.
